Finance

Beta
Lists
NRXS:NYSEAMERICAN
Neuraxis Inc
$6.80
0.00%
(0.00) 1D
Jun 10, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NRXS...
Open
$6.72
High
$6.91
Low
$6.65
Mkt. cap
84.21M
Avg. vol.
163.24K
Volume
61.81K
52-wk high
$9.33
52-wk low
$2.20
EPS
-$0.82
Shares outstanding
12.38M
No. of employees
24
Open
$6.72
High
$6.91
Low
$6.65
Mkt. cap
84.21M
Avg. vol.
163.24K
Volume
61.81K
52-wk high
$9.33
52-wk low
$2.20
EPS
-$0.82
Shares outstanding
12.38M
No. of employees
24
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to NRXS in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for NRXS in the last 3 months.
Highest
Current $6.80
(-100.00%)
Average
(-100.00%)
Lowest
(-100.00%)
News stories
From sources across the web
About Neuraxis Inc
CEO-
Employees24
Founded2011
HeadquartersCarmel, Indiana, United States
SectorMedical device
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
894.09K
811.41K
968.13K
1.61M
Cost of goods sold
146.64K
135.49K
141.65K
218.37K
Cost of revenue
146.64K
135.49K
141.65K
218.37K
Research and development expenses
58.32K
130.85K
146.18K
99.57K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.40M
2.65M
2.40M
3.03M
Operating expense
2.45M
2.78M
2.54M
3.13M
Total operating expenses
2.60M
2.91M
2.68M
3.35M
Operating income
-1.71M
-2.10M
-1.72M
-1.74M
Other non operating income
40.87K
6.95K
36.85K
5.44K
EBT including unusual items
-1.69M
-2.12M
-1.71M
-1.76M
EBT excluding unusual items
-1.68M
-2.12M
-1.71M
-1.76M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.69M
-2.12M
-1.71M
-1.76M
Net profit margin
-189.07%
-261.62%
-176.49%
-109.55%
Earnings per share
-0.22
-0.24
-0.10
-0.18
Interest and investment income
-
-
-
-
Interest expense
-13.43K
-29.66K
-28.64K
-26.19K
Net interest expenses
-13.43K
-29.66K
-28.64K
-26.19K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.69M
-2.08M
-1.69M
-1.72M
Gain or loss from assets sale
-365.00
7.71K
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more